Funded Tech Companies
SanegeneBio
Based in Woburn, SanegeneBio has funding from Eli Lilly and Company, Symbiosis and Invus.
Company Overview
Company Name
SanegeneBio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
300 Tradecenter Dr
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
SanegeneBio is a global biotech with a singular vision: Best-in-class RNAi medicines. We are focused on discovering and developing best-in-class genetic medicines for obesity, cardiometabolic, and autoimmune diseases using RNA interference (RNAi) technology. Our proprietary technology platform, LEAD� (Ligand and Enhancer Assisted Delivery), enables tissue-specific silencing of disease-driving genes in the liver, adipose tissue, muscle, and immune cells--achieved through safe, infrequent subcutaneous dosing. SanegeneBio is committed to advancing transformative RNAi therapies that address global unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/12/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Weimin Wang
Company Investors
- Eli Lilly and Company
- Symbiosis
- Invus
- Vivo Capital
- Legend Capital
- SinoPharm Capital
- Lake Bleu Capital
Browse more funded tech companies:
Sane Solutions | Sanera Systems
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs